Sarcoidosis clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • CXCL9 as a Biomarker of Acthar Efficacy

    open to eligible people ages 18-65

    The objective is this study is to test whether use of Acthar gel in the context of sarcoidosis will lead to improved symptoms and lung function and correlate with decreased levels of predictive blood biomarkers, like chemokine ligand 9 (CXCL9).

    at UCSF

  • BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

    at UCLA UCSF

Our lead scientists for Sarcoidosis research studies include .

Last updated: